These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

527 related articles for article (PubMed ID: 23842215)

  • 81. Early effects of total paracentesis and albumin infusion on muscle sympathetic nerve activity in cirrhotic patients with tense ascites.
    Pozzi M; Grassi G; Pecci V; Turri C; Boari G; Bolla GB; Dell'Oro R; Massironi S; Roffi L; Mancia G
    J Hepatol; 1999 Jan; 30(1):95-100. PubMed ID: 9927155
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Total paracentesis with dextran 40 vs diuretics in the treatment of ascites in cirrhosis: a randomized controlled study.
    Solà R; Vila MC; Andreu M; Oliver MI; Coll S; Gana J; Ledesma S; Ginès P; Jiménez W; Arroyo V
    J Hepatol; 1994 Feb; 20(2):282-8. PubMed ID: 7516361
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Predictors of clinical response to transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients with refractory ascites.
    Deschênes M; Dufresne MP; Bui B; Fenyves D; Spahr L; Roy L; Lafortune M; Pomier-Layrargues G
    Am J Gastroenterol; 1999 May; 94(5):1361-5. PubMed ID: 10235219
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Effect of different therapeutic modalities on systemic, renal, and hepatic hemodynamics and short-term outcomes in cirrhotic patients with spontaneous bacterial peritonitis.
    Salman TA; Edrees AM; El-Said HH; El-Abd OL; El-Azab GI
    Eur J Gastroenterol Hepatol; 2016 Jul; 28(7):777-85. PubMed ID: 27097354
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Predictors of large volume paracantesis induced circulatory dysfunction in patients with massive hepatic ascites.
    Nasr G; Hassan A; Ahmed S; Serwah A
    J Cardiovasc Dis Res; 2010 Jul; 1(3):136-44. PubMed ID: 21187868
    [TBL] [Abstract][Full Text] [Related]  

  • 86. The effects of chronic treatment with octreotide versus octreotide plus midodrine on systemic hemodynamics and renal hemodynamics and function in nonazotemic cirrhotic patients with ascites.
    Kalambokis G; Economou M; Fotopoulos A; Al Bokharhii J; Pappas C; Katsaraki A; Tsianos EV
    Am J Gastroenterol; 2005 Apr; 100(4):879-85. PubMed ID: 15784036
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Renal and circulatory effects of large volume plasma expansion in patients with hepatorenal syndrome type 1.
    Umgelter A; Wagner KS; Reindl W; Luppa PB; Geisler F; Huber W; Schmid RM
    Ann Hepatol; 2012; 11(2):232-9. PubMed ID: 22345341
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Large-volume paracentesis versus dialytic ultrafiltration in the treatment of cirrhotic ascites.
    Lai KN; Li P; Law E; Swaminathan R; Nicholls MG
    Q J Med; 1991 Jan; 78(285):33-41. PubMed ID: 1670062
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Mechanisms of early decrease in systemic vascular resistance after total paracentesis: influence of flow rate of ascites extraction.
    Coll S; Vila MC; Molina L; Gimenez MD; Guarner C; Solà R
    Eur J Gastroenterol Hepatol; 2004 Mar; 16(3):347-53. PubMed ID: 15195901
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Midodrine and albumin versus albumin alone for the secondary prophylaxis of acute kidney injury in a patient with cirrhosis and ascites.
    Sharma P; Puri P; Bansal N; Singla V; Kumar A; ShriHari AA; Arora A
    Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e499-e504. PubMed ID: 34034268
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Effects of a selective vasopressin V2 receptor antagonist, satavaptan, on ascites recurrence after paracentesis in patients with cirrhosis.
    Wong F; Gines P; Watson H; Horsmans Y; Angeli P; Gow P; Minini P; Bernardi M
    J Hepatol; 2010 Aug; 53(2):283-90. PubMed ID: 20541828
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The management of hepatorenal syndrome.
    Carl DE; Sanyal A
    Minerva Gastroenterol Dietol; 2009 Jun; 55(2):207-26. PubMed ID: 19305378
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Does the evidence support a survival benefit of albumin infusion in patients with cirrhosis undergoing large-volume paracentesis?
    Bernardi M; Caraceni P; Navickis RJ
    Expert Rev Gastroenterol Hepatol; 2017 Mar; 11(3):191-192. PubMed ID: 28004601
    [No Abstract]   [Full Text] [Related]  

  • 94. Paracentesis-induced circulatory dysfunction: mechanism and effect on hepatic hemodynamics in cirrhosis.
    Ruiz-del-Arbol L; Monescillo A; Jimenéz W; Garcia-Plaza A; Arroyo V; Rodés J
    Gastroenterology; 1997 Aug; 113(2):579-86. PubMed ID: 9247479
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Clinical, biochemical, and hormonal changes after a single, large-volume paracentesis in cirrhosis with ascites.
    Gentile S; Angelico M; Bologna E; Capocaccia L
    Am J Gastroenterol; 1989 Mar; 84(3):279-84. PubMed ID: 2645767
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Post-paracentesis circulatory derangements are related to monocyte activation.
    Carl DE; Ghosh S; Cheng J; Gehr TW; Stravitz RT; Sanyal A
    Liver Int; 2014 Aug; 34(7):1001-7. PubMed ID: 24373155
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Midodrine plus propranolol versus propranolol alone in preventing first bleed in patients with cirrhosis and severe ascites: a randomized controlled trial.
    Ranjan A; Jindal A; Maiwall R; Vashishtha C; Vijayaraghavan R; Arora V; Sarin SK
    Hepatol Int; 2024 Aug; 18(4):1261-1270. PubMed ID: 38727780
    [TBL] [Abstract][Full Text] [Related]  

  • 98. [Treatment of ascites in patients with liver cirrhosis without neither hyponatremia nor renal insufficiency. Results of a randomized study comparing diuretics and punctures compensated by albumin].
    Hagège H; Ink O; Ducreux M; Pelletier G; Buffet C; Etienne JP
    Gastroenterol Clin Biol; 1992; 16(10):751-5. PubMed ID: 1478401
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Standardizing the Use of Albumin in Large Volume Paracentesis.
    Anderson SS; McCreary JB; Alvarez KS; Brown LS; Agrawal D
    J Pharm Pract; 2020 Aug; 33(4):420-424. PubMed ID: 30522384
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Management of ascites in patients with liver cirrhosis: recent evidence and controversies.
    Hsu SJ; Huang HC
    J Chin Med Assoc; 2013 Mar; 76(3):123-30. PubMed ID: 23497963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.